MedPath

FOX CHASE CANCER CENTER

🇺🇸United States
Ownership
-
Established
1904-01-01
Employees
-
Market Cap
-
Website
http://www.foxchase.org

Bevacizumab With or Without Docetaxel in Treating Patients With Previously Treated Metastatic Pancreatic Cancer

Phase 2
Terminated
Conditions
Pancreatic Cancer
Interventions
First Posted Date
2003-08-07
Last Posted Date
2021-03-05
Lead Sponsor
Fox Chase Cancer Center
Target Recruit Count
32
Registration Number
NCT00066677
Locations
🇺🇸

Fox Chase Cancer Center - Philadelphia, Philadelphia, Pennsylvania, United States

SU5416 in Treating Patients With Refractory or Relapsed Multiple Myeloma

Phase 2
Completed
Conditions
Multiple Myeloma and Plasma Cell Neoplasm
First Posted Date
2003-06-25
Last Posted Date
2013-07-11
Lead Sponsor
Fox Chase Cancer Center
Target Recruit Count
21
Registration Number
NCT00006013
Locations
🇺🇸

University of Chicago Cancer Research Center, Chicago, Illinois, United States

🇺🇸

Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

and more 1 locations

Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Phase 2
Completed
Conditions
Leukemia
Lymphoma
First Posted Date
2003-06-06
Last Posted Date
2013-07-11
Lead Sponsor
Fox Chase Cancer Center
Target Recruit Count
5
Registration Number
NCT00062296
Locations
🇺🇸

Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

Neoadjuvant Chemoradiotherapy Followed By Surgery in Treating Patients With Limited-Stage Small Cell Lung Cancer

Phase 1
Completed
Conditions
Lung Cancer
First Posted Date
2003-06-06
Last Posted Date
2010-02-12
Lead Sponsor
Fox Chase Cancer Center
Registration Number
NCT00062322
Locations
🇺🇸

Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

Comparison of Two Radiation Therapy Regimens in Treating Patients With Stage II or Stage III Prostate Cancer

Phase 3
Completed
Conditions
Prostate Cancer
Interventions
Radiation: radiation therapy
First Posted Date
2003-06-06
Last Posted Date
2016-03-03
Lead Sponsor
Fox Chase Cancer Center
Target Recruit Count
307
Registration Number
NCT00062309
Locations
🇺🇸

Fox Chase Cancer Center - Philadelphia, Philadelphia, Pennsylvania, United States

Comparison of Biomarkers Based on Fine-Needle Aspiration in Women at Increased or Normal Risk of Breast Cancer

Not Applicable
Withdrawn
Conditions
Breast Cancer
First Posted Date
2003-05-26
Last Posted Date
2013-07-11
Lead Sponsor
Fox Chase Cancer Center
Registration Number
NCT00041353

Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer

Phase 2
Completed
Conditions
Lung Cancer
Interventions
Procedure: conventional surgery
Radiation: radiation therapy
First Posted Date
2003-05-07
Last Posted Date
2022-02-03
Lead Sponsor
Fox Chase Cancer Center
Target Recruit Count
19
Registration Number
NCT00043108
Locations
🇺🇸

Fox Chase Cancer Center - Philadelphia, Philadelphia, Pennsylvania, United States

Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Phase 3
Withdrawn
Conditions
Lung Cancer
First Posted Date
2003-02-06
Last Posted Date
2013-07-11
Lead Sponsor
Fox Chase Cancer Center
Registration Number
NCT00054392
Locations
🇺🇸

Fallon Clinic at Worcester Medical Center, Worcester, Massachusetts, United States

🇺🇸

Aultman Hospital Cancer Center at Aultman Health Foundation, Canton, Ohio, United States

🇺🇸

David Lee Outpatient Cancer Center at Charleston Area Medical Center, Charleston, West Virginia, United States

and more 53 locations

Temozolomide in Treating Patients With Relapsed or Progressive Small Cell Lung Cancer

Phase 2
Completed
Conditions
Lung Cancer
Interventions
First Posted Date
2003-01-27
Last Posted Date
2013-07-11
Lead Sponsor
Fox Chase Cancer Center
Target Recruit Count
7
Registration Number
NCT00022711
Locations
🇺🇸

Kimball Medical Center, Lakewood, New Jersey, United States

🇺🇸

Fox Chase Cancer Center at Virtua Memorial Hospital Burlington County, Mount Holly, New Jersey, United States

🇺🇸

South Jersey Regional Cancer Center, Millville, New Jersey, United States

and more 14 locations

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer

Phase 2
Completed
Conditions
Esophageal Cancer
First Posted Date
2003-01-27
Last Posted Date
2014-05-09
Lead Sponsor
Fox Chase Cancer Center
Target Recruit Count
21
Registration Number
NCT00021320
Locations
🇺🇸

Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath